Bill Commons

NY S 10298

in committee

Enacts the "Terminate Excessive Cross-state Actuarial Subsidization (TEXAS) Act"

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 10298 pass?

Not yet. NY S 10298 is in committee as of 2026-05-12 and has not come to a final vote. Latest recorded action (2026-05-12): REFERRED TO INSURANCE

What is NY S 10298 about?

Enacts the "Terminate Excessive Cross-state Actuarial Subsidization (TEXAS) Act" which requires life insurance companies to take state specific population health information into account as a factor; requires the superintendent of financial services to develop a standard weight to be given to state specific population health information in rate-setting.

Who sponsors NY S 10298?

James Skoufis is the primary sponsor of NY S 10298.

Description

Enacts the "Terminate Excessive Cross-state Actuarial Subsidization (TEXAS) Act" which requires life insurance companies to take state specific population health information into account as a factor; requires the superintendent of financial services to develop a standard weight to be given to state specific population health information in rate-setting.

Introduced
Latest action
2026-05-12 — REFERRED TO INSURANCE
Bill type
bill
Last updated

Sponsors

  • James Skoufisprimary

Committees

Not provided by source.

Action timeline

  1. 2026-05-12

    REFERRED TO INSURANCE

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 10298. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.